Medicines Classification




NEW ZEALAND GAZETTE, No. 153 — 18 DECEMBER 2014

Rupatadine

Ruxolitinib

Sapropterin

Selective androgen receptor modulators

Sildenafil and its structural analogues; except sildenafil in medicines for oral use containing 100 milligrams or less per dose unit when sold in the manufacturer’s original pack containing not more than 12 solid dosage units for the treatment of erectile dysfunction in males aged 35–70 years by a registered pharmacist who has successfully completed a training programme endorsed by the Pharmaceutical Society of New Zealand

Simeprevir

Sofosbuvir

Tafluprost

Taliglucerase alfa

Telaprevir

Terbinafine; except in medicines for dermal use

Teriflunomide

Tesamorelin

Ticagrelor

Tioconazole; except in medicines for vaginal or dermal use

Trametinib dimethyl sulfoxide

Tolvaptan

Trastuzumab emtansine

Trimethoprim; except in medicines for oral use containing 300 milligrams or less per dose unit when sold in a pack of 3 solid dosage units to a woman aged 16–65 years for the treatment of an uncomplicated urinary tract infection by a registered pharmacist who has successfully completed the New Zealand College of Pharmacists’ training in the treatment of urinary tract infections

Tuberculin

Umeclidinium bromide

Vandetanib

Varicella vaccine; except when administered for the prevention of herpes zoster (shingles) to a person 50 years of age or over by a registered pharmacist who has successfully completed a vaccinator training course approved by the Ministry of Health and who is complying with the immunisation standards of the Ministry of Health

Vedolizumab

Velaglucerase alfa

Vemurafenib

Vilanterol

Vismodegib

Vorinostat

Vortioxetine

Zoster immunoglobulin, human

Schedule 2

Restricted Medicines

Adrenaline; in medicines containing 1% or less except in medicines for injection containing 0.02% or less

Brompheniramine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of anxiety or insomnia; for oral use for the treatment of anxiety or insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

Chlorpheniramine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of anxiety or insomnia; for oral use for the treatment of anxiety or insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

Ciclopirox; for external use in medicines containing more than 2%; in preparations for application to the nails

163



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2014, No 153





✨ LLM interpretation of page content

🏥 Classification of Medicines (continued from previous page)

🏥 Health & Social Welfare
Medicines Act 1981, Prescription Medicines, Restricted Medicines, Pharmacy-Only Medicines, Rupatadine, Ruxolitinib, Sapropterin, Selective androgen receptor modulators, Sildenafil, Simeprevir, Sofosbuvir, Tafluprost, Taliglucerase alfa, Telaprevir, Terbinafine, Teriflunomide, Tesamorelin, Ticagrelor, Tioconazole, Trametinib dimethyl sulfoxide, Tolvaptan, Trastuzumab emtansine, Trimethoprim, Tuberculin, Umeclidinium bromide, Vandetanib, Varicella vaccine, Vedolizumab, Velaglucerase alfa, Vemurafenib, Vilanterol, Vismodegib, Vorinostat, Vortioxetine, Zoster immunoglobulin, Adrenaline, Brompheniramine, Chlorpheniramine, Ciclopirox